Ascendis Pharma ADR (ASND)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | ASND | ROIV | EXEL | ||
| Company | Ascendis Pharma ADR | Roivant Sciences Ltd | Exelixis Inc | ||
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | ||
| Open | 146.59 | 12.30 | 27.66 | ||
| High | 150.43 | 12.38 | 27.73 | ||
| Low | 145.77 | 11.93 | 26.56 | ||
| Last | 148.88 | 12.00 | 26.82 | ||
| Change | +2.29 | -0.05 | -0.78 | ||
| % Change | +1.56% | -0.41% | -2.83% | ||
| Volume | 885,400 | 14,961,999 | 1,707,000 | ||
| 20-Day Average Volume | 940,925 | 5,728,110 | 1,499,925 | ||
| Previous Close | 146.59 | 12.05 | 27.60 | ||
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | ||
| Has Options | Yes | Yes | Yes | ||
| Technicals | |||||
| 20-Day Moving Average | 130.68 | 12.02 | 26.13 | ||
| 20-Day Raw Stochastic | 96.06% | 34.27% | 62.73% | ||
| 20-Day Relative Strength | 63.81% | 55.36% | 60.20% | ||
| Weighted Alpha | +41.55 | +20.25 | +30.30 | ||
| Today's Opinion | 8% Buy | 88% Buy | 100% Buy | ||
| Previous Opinion | 8% Buy | 100% Buy | 100% Buy | ||
| Last Month's Opinion | 24% Buy | 56% Buy | 100% Buy | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | +31.83% since 09/11/24 | -3.07% since 09/11/24 | +0.71% since 09/11/24 | ||
| Low | 111.09 on 09/12/24 | 11.81 on 09/16/24 | 26.17 on 09/12/24 | ||
| High | 150.43 on 09/18/24 | 12.39 on 09/12/24 | 27.83 on 09/17/24 | ||
| 1-Month | |||||
| %Chg | +7.23% since 08/16/24 | +7.24% since 08/16/24 | +1.78% since 08/16/24 | ||
| Low | 111.09 on 09/12/24 | 11.17 on 08/19/24 | 25.12 on 09/09/24 | ||
| High | 150.43 on 09/18/24 | 13.06 on 09/09/24 | 27.83 on 09/17/24 | ||
| 3-Month | |||||
| %Chg | +20.85% since 06/18/24 | +10.70% since 06/18/24 | +24.40% since 06/18/24 | ||
| Low | 111.09 on 09/12/24 | 10.00 on 08/05/24 | 21.36 on 06/20/24 | ||
| High | 150.43 on 09/18/24 | 13.06 on 09/09/24 | 27.83 on 09/17/24 | ||
| 6-Month | |||||
| %Chg | +1.24% since 03/18/24 | +21.58% since 03/18/24 | +15.75% since 03/18/24 | ||
| Low | 111.09 on 09/12/24 | 9.76 on 03/19/24 | 20.14 on 05/29/24 | ||
| High | 156.84 on 04/10/24 | 13.06 on 09/09/24 | 27.83 on 09/17/24 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 8,536,081 | 8,901,600 | 8,368,321 | ||
| Shares Outstanding, K | 58,231 | 738,722 | 303,200 | ||
| Annual Sales | 288,670,000 | 124,800,000 | 1,830,210,000 | ||
| Annual Net Income | -521,070,000 | 4,348,930,000 | 207,770,000 | ||
| Last Quarter Sales | 38,770,000 | 55,130,000 | 637,180,000 | ||
| Last Quarter Net Income | -117,790,000 | 95,300,000 | 226,120,000 | ||
| 60-Month Beta | 0.63 | 1.25 | 0.54 | ||
| Per-Share Information | |||||
| Most Recent Earnings | -2.05 on 09/03/24 | -0.18 on 08/08/24 | 0.84 on 08/06/24 | ||
| Latest Earnings Date | 11/05/24 | 11/11/24 | 11/06/24 | ||
| Most Recent Dividend | N/A | N/A | N/A | ||
| Next Ex-Dividends Date | N/A | N/A | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 0.00 | 24.10 | ||